We are live on ! Find out more
PCRX icon

Pacira BioSciences

239 hedge funds and large institutions have $1.24B invested in Pacira BioSciences in 2025 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 67 increasing their positions, 95 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

374% more call options, than puts

Call options by funds: $3.13M | Put options by funds: $661K

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

23% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 30

3% more funds holding

Funds holding: 233239 (+6)

2% more capital invested

Capital invested by funds: $1.21B → $1.24B (+$28.4M)

2.41% less ownership

Funds ownership: 109.17%106.76% (-2.4%)

29% less repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 95

Holders
239
Holders Change
+6
Holders Change %
+2.58%
% of All Funds
3.14%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
37
Increased
67
Reduced
95
Closed
30
Calls
$3.13M
Puts
$661K
Net Calls
+$2.47M
Net Calls Change
-$2.36M
Name Holding Trade Value Shares
Change
Change in
Stake
Teacher Retirement System of Texas
151
Teacher Retirement System of Texas
Texas
$293K -$26.8K -1,092 -9%
State of Tennessee, Department of Treasury
152
State of Tennessee, Department of Treasury
Tennessee
$291K
PA
153
Profund Advisors
Maryland
$271K -$42.2K -1,718 -14%
SOW
154
State of Wyoming
Wyoming
$269K +$152K +6,177 +145%
ProShare Advisors
155
ProShare Advisors
Maryland
$264K -$43.1K -1,754 -15%
OPERF
156
Oregon Public Employees Retirement Fund
Oregon
$262K -$9.82K -400 -4%
OAM
157
OP Asset Management
$262K +$250K +10,159 New
First Trust Advisors
158
First Trust Advisors
Illinois
$251K +$239K +9,742 New
Allspring Global Investments
159
Allspring Global Investments
North Carolina
$248K -$25.2K -1,025 -9%
QCM
160
Quantinno Capital Management
New York
$239K -$90.2K -3,672 -28%
Wealth Enhancement Advisory Services
161
Wealth Enhancement Advisory Services
Minnesota
$222K +$3.76K +153 +2%
FFA
162
Farther Finance Advisors
California
$211K +$295 +12 +0.1%
Carson Wealth (CWM LLC)
163
Carson Wealth (CWM LLC)
Nebraska
$207K -$33.5K -1,362 -14%
CUAMC
164
China Universal Asset Management Company
China
$203K -$35K -1,424 -15%
Public Employees Retirement Association of Colorado
165
Public Employees Retirement Association of Colorado
Colorado
$176K
VEA
166
Virtus ETF Advisers
New York
$174K
CJ
167
Caitlin John
Michigan
$108K +$103K +4,205 New
SO
168
STRS Ohio
Ohio
$106K
AIP
169
Ameritas Investment Partners
Nebraska
$99.1K -$16.7K -680 -15%
VI
170
Vestcor Inc
New Brunswick, Canada
$90K +$86.1K +3,504 New
TRCT
171
Tower Research Capital (TRC)
New York
$87.4K -$30.3K -1,234 -27%
IFU
172
iSAM Funds (UK)
United Kingdom
$79.6K +$75.8K +3,087 New
GI
173
GAMMA Investing
California
$78K -$16.4K -669 -18%
PNC Financial Services Group
174
PNC Financial Services Group
Pennsylvania
$76.3K -$13.5K -549 -16%
Osaic Holdings
175
Osaic Holdings
Arizona
$60.3K -$1.1K -45 -2%

PCRX Hedge Fund Activity: Q3 2025 in Review

239 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in Pacira BioSciences (PCRX) for Q3 2025, worth a combined $1.24B — up 2.3% from $1.21B a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new PCRX positions and 30 closed out — a net gain of 7 holders — while 67 added to existing stakes and 95 trimmed.

The largest buyer was Doma Perpetual Capital Management, adding an estimated $22M. The largest seller was Polar Capital Holdings, exiting entirely with an estimated $21.8M sold.

  • 239 institutional investors held Pacira BioSciences (PCRX) as of Q3 2025, up from 233 in Q2 2025.
  • Funds reported $1.24B of Pacira BioSciences stock for Q3 2025, up 2.3% quarter-over-quarter.
  • 37 funds opened new Pacira BioSciences positions in Q3 2025 and 30 closed out, a net change of +7 holders.
  • The largest Pacira BioSciences buyer in Q3 2025 was Doma Perpetual Capital Management, an estimated $22M added.
  • The largest Pacira BioSciences seller in Q3 2025 was Polar Capital Holdings, an estimated $21.8M sold.

Based on aggregated 13F filings for Q3 2025.